Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: China and Russia Put Stocks in the Red
Options with decreasing implied volatility: OVTI SPLK SWY CIEN ARNA
Future Sales Of Arena Pharmaceuticals' BELVIQ: Let's Make Some Informed, Quantitative Predictions Using Expected Value
Arena Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript
Arena Pharmaceuticals Q4 Loss Widens
Arena sees majority of 2014 revenues to be collaborator payments, milestones
Arena Pharmaceuticals reports Q4 EPS (11c), consensus 2c
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results
Bad Day for VIVUS: Why VVUS Stock Is Tumbling
Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27
Arena Pharmaceuticals: Is The Stock Attractively Priced?